BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38017548)

  • 21. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
    Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
    J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
    Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
    Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of co-expressed gene networks promoting CD8
    Zhang C; Xiao J; Fa L; Jiang F; Jiang H; Zhou L; Xu Z
    BMC Ophthalmol; 2023 Aug; 23(1):354. PubMed ID: 37563735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the Relationship between Hub Genes and Immune Cell Infiltration in Vascular Endothelial Cells of Proliferative Diabetic Retinopathy Using Bioinformatics Methods.
    Huang J; Zhou Q
    Dis Markers; 2022; 2022():7231046. PubMed ID: 35154512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
    Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
    Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma.
    Zhang L; Li Y; Wang X; Ping Y; Wang D; Cao Y; Dai Y; Liu W; Tao Z
    J Cancer; 2021; 12(12):3626-3647. PubMed ID: 33995639
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a tumor immune cell infiltration-related gene signature for recurrence prediction by weighted gene co-expression network analysis in prostate cancer.
    Xie LY; Huang HY; Hao YL; Yu M; Zhang W; Wei E; Gao C; Wang C; Zeng L
    Front Genet; 2023; 14():1067172. PubMed ID: 37007952
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNAP25 is a potential prognostic biomarker for prostate cancer.
    Di L; Gu M; Wu Y; Liu G; Zhang L; Li Y; Zhang W
    Cancer Cell Int; 2022 Apr; 22(1):144. PubMed ID: 35392903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.
    Rui X; Shao S; Wang L; Leng J
    BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the Expression of TIE1 and Its Mediated Immunosuppression in Gastric Cancer.
    Gong Z; Zheng Q; Li B; Wang H; Chen H; Lin S
    J Cancer; 2024; 15(10):2994-3009. PubMed ID: 38706903
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
    Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
    BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new prognostic model for
    Li Q; Liu XL; Jiang N; Li QY; Song YX; Ke XX; Han H; Luo Q; Guo Q; Luo XY; Chen C
    J Thorac Dis; 2023 Apr; 15(4):1919-1934. PubMed ID: 37197482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SLAMF8 Participates in Acute Renal Transplant Rejection
    Teng L; Shen L; Zhao W; Wang C; Feng S; Wang Y; Bi Y; Rong S; Shushakova N; Haller H; Chen J; Jiang H
    Front Immunol; 2022; 13():846695. PubMed ID: 35432371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
    Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D
    Front Immunol; 2023; 14():1181370. PubMed ID: 37600770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
    Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
    Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
    Gao P; Lu W; Hu S; Zhao K
    Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.